Nexalin Technology market cap NXL
Share price times shares outstanding: what the whole company sells for, since 2022.
- Today, Nov 2, 2026
- $1.1M
- Highest close in our data
- $56.1M
- Dec 2024
Nexalin Technology is worth $1.1M at the close on Nov 2, 2026, at $1.51 a share.
That is down 95% over the last year.
Its highest close in our data was $56.1M in Dec 2024.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1.1M | $1.1M | $13.3M | −91% |
| 2025 | $11.8M | $11.8M | $47.8M | −69% |
| 2024 | $37.9M | $2.3M | $56.1M | +1161% |
| 2023 | $3M | $2.3M | $8.9M | −45% |
| 2022 | $5.5M | $5.4M | $17.1M | n/a |
Against its peers
Companies in Medical - Devices nearest Nexalin Technology's size, closest first, today.
| Company | Market cap |
|---|---|
| NXLNexalin Technology | $1.1M |
| NUWENuwellis | $2.1M |
| NDRAENDRA Life Sciences | $7.2M |
| IRIXIridex | $12.7M |
| QTIQT Imaging | $31.5M |
| POCIPrecision Optics | $52.7M |
| ECORelectroCore | $64.6M |
| OMOutset Medical | $75.6M |
| HYPRHyperfine | $76.9M |
| NRXSNeuraxis, INC | $82.9M |
| STXSStereotaxis | $88.2M |
| Peer median | $58.6M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Nexalin Technology
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.